Literature DB >> 2984402

Intestinal and serum immune response to a naturally acquired rotavirus gastroenteritis in children.

K Hjelt, P C Grauballe, P O Schiøtz, L Andersen, P A Krasilnikoff.   

Abstract

Seventeen children (mean age: 2.0 years, range: 36 days-8 years) hospitalized with acute gastroenteritis were investigated. Thirteen children had a rotavirus infection while four did not. Rotavirus serum IgA as well as ScIg, i.e., antirotavirus immunoglobulin containing secretory component, increased rapidly after rotavirus infection. While rotavirus IgA persisted in serum for at least 6 months, rotavirus ScIg disappeared from serum in less than 4 months. Rotavirus IgG could be detected in serum during the early stage of the infection and was still high after 6 months. The patients with nonrotavirus acute gastroenteritis did not show any of the above-mentioned serological hallmarks of those with rotavirus infection. The amounts of rotavirus ScIg found in serum about 1 week after the infection correlated to the amounts of rotavirus ScIg in duodenal fluid. Six months after the infection, rotavirus IgA was found in the feces of the majority of the patients while rotavirus ScIg could be detected only in one patient. The amounts of rotavirus IgA in sera and intestinal secretions showed identical patterns in the acute phase of the disease as well as after recovery. The same applied to rotavirus ScIg. These findings could be useful in future evaluations of vaccines and immunity against rotavirus infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984402     DOI: 10.1097/00005176-198502000-00012

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  12 in total

1.  Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.

Authors:  Daniel Herrera; Camilo Vásquez; Blaise Corthésy; Manuel A Franco; Juana Angel
Journal:  Hum Vaccin Immunother       Date:  2013-07-09       Impact factor: 3.452

2.  Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood.

Authors:  B S Coulson; K Grimwood; P J Masendycz; J S Lund; N Mermelstein; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection.

Authors:  J Xu; P Dennehy; H Keyserling; L E Westerman; Y Wang; R C Holman; J R Gentsch; R I Glass; B Jiang
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

4.  Comparison of immunoglobulin A (IgA), IgG, and IgM enzyme-linked immunosorbent assays, plaque reduction neutralization assay, and complement fixation in detecting seroresponses to rotavirus vaccine candidates.

Authors:  K Midthun; L Z Pang; J Flores; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

5.  Serum IgA immune response to individual rotavirus polypeptides in young children with rotavirus infection.

Authors:  K Johansen; L Granqvist; K Karlén; G Stintzing; I Uhnoo; L Svensson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Serologic and mucosal immune response to rotavirus infection in the rabbit model.

Authors:  M E Conner; M A Gilger; M K Estes; D Y Graham
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

7.  Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.

Authors:  K Grimwood; J C Lund; B S Coulson; I L Hudson; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

Review 8.  Human viral gastroenteritis.

Authors:  M L Christensen
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

Review 9.  Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings.

Authors:  E Clarke; U Desselberger
Journal:  Mucosal Immunol       Date:  2014-12-03       Impact factor: 7.313

Review 10.  Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.

Authors:  Juana Angel; A Duncan Steele; Manuel A Franco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.